ALG PHARMA

Serial Number 79196143
Registration 5445428
709

Registration Progress

Application Filed
Jul 7, 2016
Under Examination
Approved for Publication
Jan 30, 2018
Published for Opposition
Jan 30, 2018
Registered
Apr 17, 2018

Trademark Image

ALG PHARMA

Basic Information

Serial Number
79196143
Registration Number
5445428
Filing Date
July 7, 2016
Registration Date
April 17, 2018
Published for Opposition
January 30, 2018
Cancellation Date
November 1, 2024
Drawing Code
3

Status Summary

Current Status
Inactive
Status Code
709
Status Date
Nov 1, 2024

Rights Holder

AMADEITE

99
Address
2 ter rue de la Fontaine
BREHAN F-56580
FR

Ownership History

AMADEITE

Original Applicant
99
FR

AMADEITE

Owner at Publication
99
FR

AMADEITE

Original Registrant
99
FR

Legal Representation

Attorney
Jeannine A Rittenhouse

USPTO Deadlines

Next Deadline
1012 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2018-04-17)
Due Date
April 17, 2028
Grace Period Ends
October 17, 2028

Application History

40 events
Date Code Type Description
Jul 1, 2025 INTR P TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 1, 2024 C71T O CANCELLED SECTION 71
Apr 17, 2023 REM3 E COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 25, 2022 ADCH M CHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 25, 2022 NREP P NEW REPRESENTATIVE AT IB RECEIVED
Jun 14, 2021 COC. O CORRECTION UNDER SECTION 7 - PROCESSED
Apr 19, 2021 COC. O CORRECTION UNDER SECTION 7 - PROCESSED
Sep 21, 2018 LIME I LIMITATION FROM THE IB EXAMINED AND ENTERED
Aug 31, 2018 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 17, 2018 LIMG M LIMITATION OF GOODS RECEIVED FROM IB
Aug 4, 2018 FICS P FINAL DISPOSITION NOTICE SENT TO IB
Aug 4, 2018 FIMP P FINAL DISPOSITION PROCESSED
Jul 17, 2018 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 17, 2018 R.PR A REGISTERED-PRINCIPAL REGISTER
Jan 30, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 30, 2018 PUBO A PUBLISHED FOR OPPOSITION
Jan 26, 2018 GPNX P NOTIFICATION PROCESSED BY IB
Jan 10, 2018 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 10, 2018 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 10, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 21, 2017 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 21, 2017 XAEC I EXAMINER'S AMENDMENT ENTERED
Dec 21, 2017 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 21, 2017 GNEA O EXAMINERS AMENDMENT E-MAILED
Dec 21, 2017 CNEA R EXAMINERS AMENDMENT -WRITTEN
Jul 6, 2017 CNFR R FINAL REFUSAL WRITTEN
Jul 6, 2017 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 6, 2017 GNFR O FINAL REFUSAL E-MAILED
Jun 8, 2017 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 7, 2017 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 7, 2017 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 24, 2016 RFNT P REFUSAL PROCESSED BY IB
Dec 7, 2016 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 7, 2016 RFRR P REFUSAL PROCESSED BY MPU
Nov 24, 2016 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 23, 2016 CNRT R NON-FINAL ACTION WRITTEN
Nov 22, 2016 MAFR O APPLICATION FILING RECEIPT MAILED
Nov 18, 2016 DOCK D ASSIGNED TO EXAMINER
Nov 18, 2016 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 17, 2016 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB

Additional Information

Design Mark
The mark consists of the wording "ALG PHARMA" in teal, appearing above three curved bands; a teal band is just above a light blue band, with a green hand appearing across the middle of the two.
Color Claim
The color(s) teal, light blue and green is/are claimed as a feature of the mark.
Other
In the Statement, classes 1, 5, and 42 have been corrected per the Fnote dated 9/21/2018.
Other
In the Statement, class 5 has been corrected per the Fnote dated 6/8/2021.

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMA"